The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses
Open accessAbstract
Serologic Response to 2 DosesStudies have reported low seroconversion rates (58% after the second dose) in solid organ transplant recipients who received a messenger RNA (mRNA) SARS-CoV-2 vaccine.1,2 Based on this evidence, the French National Authority for Health issued a recommendation in April 2021 to administer a third vaccine dose in immunosuppressed patients who did not respond after 2 doses.We examined the antibody responses of kidney transplant recipients who did not respond to 2 doses and received a third dose (100 μg) of the mRNA-1273 (Moderna) vaccine.Methods | All kidney transplant recipients followed up in the outpatient Kidney Transplantation Department of Strasbourg University Hospital between January 20, 2021, and June 3, 2021, with a negative history for COVID-19 and SARS-CoV-2 antispike IgG levels less than 50 arbitrary units (AU) per milliliter on the day of the first vaccine injection and 1 month after the second dose were included.All patients received a third vaccine dose between April 9, 2021, and May 12, 2021.The study protocol was approved by the local ethics committee and written informed consent was obtained.Anti-receptor-binding domain IgG response after the third vaccine dose was assessed using the ARCHITECT IgG II Quant test (Abbott).According to the manufacturer, titers greater than 50 AU/mL were considered positive (detection range, 6.8-80 000 AU/mL; positive agreement, 99.4%; negative agreement, 99.6%).The results of this assay have been SI conversion factor: To convert creatinine values to mmol/L, multiply by 88.4. a Model adjusted for sex, BMI, donor type, time from kidney transplantation, serum creatinine level, triple immunosuppression (tacrolimus + MMF/MPA + steroids), and antibody titers after the second dose.b Calculated as weight in kilograms divided by height in meters squared.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
Boyarsky, B. J., Werbel, W. A., Avery, R. K., Tobian, A. A. R., Massie, A. B., Segev, D. L., & Garonzik-Wang, J. M. (2021) · JAMA · doi:10.1001/jama.2021.7489 · Cited by 955
Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Kamar, N., Abravanel, F., Marion, O., Couat, C., Izopet, J., & Del Bello, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2108861 · Cited by 810
Boyarsky, B. J., Werbel, W. A., Avery, R. K., Tobian, A. A. R., Massie, A. B., Segev, D. L., & Garonzik-Wang, J. M. (2021) · JAMA · doi:10.1001/jama.2021.4385 · Cited by 508
Werbel, W. A., Boyarsky, B. J., Ou, M. T., Massie, A. B., Tobian, A. A. R., Garonzik-Wang, J. M., & Segev, D. L. (2021) · Annals of Internal Medicine · doi:10.7326/l21-0282 · Cited by 333
Prendecki, M., Clarke, C., Brown, J., Cox, A., Gleeson, S., Guckian, M., Randell, P., Pria, A. D., Lightstone, L., Xu, X.-N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00502-x · Cited by 271
Occurrence of severe COVID-19 in vaccinated transplant patients
Caillard, S., Chavarot, N., Bertrand, D., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.05.011 · Cited by 116
Self-citation
Cited by
Fiolet, T., Kherabi, Y., MacDonald, C.-J., Ghosn, J., & Peiffer-Smadja, N. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.005 · Cited by 911
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Lee, A. R. Y. B., Wong, S. Y., Chai, L. Y. A., Lee, S. C., Lee, M. X., Muthiah, M. D., Tay, S. H., Teo, C. B., Tan, B. K. J., Chan, Y. H., et al. (2022) · BMJ · doi:10.1136/bmj-2021-068632 · Cited by 498
COVID-19 vaccine development: milestones, lessons and prospects
Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 434
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
(2022) · doi:10.1016/j.cell.2022.01.027 · Cited by 179
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Lederer, K., Parvathaneni, K., Painter, M. M., Bettini, E., Agarwal, D., Lundgreen, K. A., Weirick, M., Goel, R. R., Xu, X., Drapeau, E. M., et al. (2021) · doi:10.1101/2021.09.16.21263686 · Cited by 179
Metadata
- Authors
- Benotmane, I., Gautier, G., Perrin, P., Olagne, J., Cognard, N., Fafi-Kremer, S., & Caillard, S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2021-09-21
- Volume
- 326
- Issue
- 11
- Pages
- 1063
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W3183904285
- Cited by
- 324
- References
- 6
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. https://app.cochat.ai/papers/10.1001/jama.2021.12339
- The paper
- Benotmane, I., Gautier, G., Perrin, P., Olagne, J., Cognard, N., Fafi-Kremer, S., & Caillard, S. (2021). Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. JAMA. https://doi.org/10.1001/jama.2021.12339
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.